Prevalence of Venous Thromboembolism and Anticoagulant Use in Patients with COVID-19 in Alberta, Canada.

ABSTRACT:

Background

COVID-19 causes a hypercoagulable state and increases the risk of venous thromboembolism (VTE).

Objectives

The primary objective was to identify VTE prevalence among patients with COVID-19 in one Canadian province. Secondary objectives were to identify the prevalence of bleeding, describe anticoagulation prescribing practices, and identify factors contributing to VTE in these patients.

Methods

Adult patients admitted to Alberta hospitals between March and December 2020 with COVID-19 who had a length of stay of at least 72 hours were included in this retrospective study. VTE, bleeding events, and comorbidities were defined by International Classification of Diseases and Related Health Problems, 10th Revision codes. Cases of VTE and controls (no VTE) w

SUBMITTER: Schultz L 

PROVIDER: S-EPMC9524556 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature